TAVERAS ARTHUR (Chief Scientific Officer) sold 0.9% of their position (928.00 shares) of X4 PHARMACEUTICALS, INC on the open market
Open‑market sale worth $863.04 — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 2/15/2023ACC: 0001628280-23-003759
Officer· Chief Scientific Officer
Since Nov 2020
-928.00
Net shares
Net seller
$863.04
Total sold
1
Open market trades
0B · 1S
1
Total transactions
928.00 disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−928.00
Price / share
$0.93
Trade value
$863.04
% of position
0.9%
2/13/2023
104.11K→103.18K
Total
Net shares
−928.00
Net value
-$863.04
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/13/2023 | S · Sale | −928.00 | $0.93 | $863.04 | 0.9% | 104.11K | 103.18K |
| Total | −928.00 | -$863.04 | ||||||
Derivative Transactions0
No derivative transactions reported